---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252919153.md"
description: "The Nasdaq Biotechnology Index rose by more than 2.4%. Among them, Editas Medicine increased by 34.72%, Arcturus Therapeutics Holdings Inc. rose by 29.01%, and Stoke Therapeutics climbed by 24.98%. In contrast, Pliant fell by 6.25%, Autolus Therapeutics dropped by 14.62%, and Zevra Therapeutics decreased by 19.81%"
datetime: "2025-08-13T20:56:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252919153.md)
  - [en](https://longbridge.com/en/news/252919153.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252919153.md)
generator: "portal-rs"
---

# 

The Nasdaq Biotechnology Index closed up more than 2.4%, with constituent stock Editas Medicine rising 34.72%, Arcturus Therapeutics Holdings Inc. up 29.01%, and Stoke Therapeutics up 24.98%, ranking third in performance. Pliant, on the other hand, fell 6.25%, ranking third in decline, while Autolus Therapeutics dropped 14.62% and Zevra Therapeutics fell 19.81%

### Related Stocks

- [STOK.US](https://longbridge.com/en/quote/STOK.US.md)
- [ARCT.US](https://longbridge.com/en/quote/ARCT.US.md)
- [EDIT.US](https://longbridge.com/en/quote/EDIT.US.md)

## Related News & Research

- [Fed's Hammack signals support for gradual rate-hike path](https://longbridge.com/en/news/305342093.md)
- [The S&P 500 is shrugging off Nvidia's selloff. Here's what's keeping the rest of the market afloat.](https://longbridge.com/en/news/305355417.md)
- [Cerebras Systems (CBRS) Could Be 76% Undervalued After Lifted Revenue Guidance](https://longbridge.com/en/news/305380352.md)
- [Nvidia options traders bank on longer-term stock recovery](https://longbridge.com/en/news/305359219.md)
- ['Not Yet,' Says Investor About SpaceX Stock](https://longbridge.com/en/news/305357492.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**